Corpus ID: 19668883

The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.

@article{Zheng2007TheEA,
  title={The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.},
  author={J. Zheng and L. Yang and Y. Wu and P. Chen and Z. Wen and W. Huang and Y. Shi and Changzheng Wang and S. Huang and T. Sun and G. Wang and S. Xiong and N. Zhong},
  journal={Chest},
  year={2007},
  volume={132 6},
  pages={
          1756-63
        }
}
  • J. Zheng, L. Yang, +10 authors N. Zhong
  • Published 2007
  • Medicine
  • Chest
  • BACKGROUND Few studies of the efficacy and safety of therapy with combinations of salmeterol/fluticasone propionate (SFCs) have been conducted in Chinese patients with COPD, and the benefits of combination therapy in nonsmoking patients with COPD are, to our knowledge, not known. STUDY OBJECTIVES The aims were to establish the efficacy and tolerability of the therapy with SFC (salmeterol, 50 microg/fluticasone, 500 microg, twice daily) in the management of Chinese COPD patients and to… CONTINUE READING
    Health status in the TORCH study of COPD: treatment efficacy and other determinants of change
    • 63
    • PDF